martes, 30 de enero de 2018

Childhood Brain Stem Glioma Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Childhood Brain Stem Glioma Treatment (PDQ®)—Health Professional Version - National Cancer Institute

National Cancer Institute

Childhood Brain Stem Glioma Treatment (PDQ®)–Health Professional Version





SECTIONS



Changes to This Summary (01/24/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text to state that reirradiation has been shown to prolong survival and can be considered at first progression in children who have had an initial response to radiation therapy (cited Janssens et al. as reference 1).
Added text to state that patients with a brain stem glioma may be enrolled on the APEC1621 trial if tissue is available from a diagnostic biopsy.
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: January 24, 2018

No hay comentarios:

Publicar un comentario